Seer: Mark McClellan
San Francisco-based life science and health data firm Seer has appointed Mark McClellan to its board of directors. McClellan currently serves as a professor of business, medicine, and health policy at Duke University's Duke-Margolis Center for Health Policy. Prior to Duke, McClellan served as administrator of the Centers for Medicare & Medicaid Services and commissioner of the US Food and Drug Administration.
OncoCell MDx: Kirk Wojno
Royal Oak, Michigan-based OncoCell MDx, an immunogenomics company developing non-invasive molecular diagnostic assays, has named Kirk Wojno as chief medical officer. Wojno formerly served as the head of urologic pathology at the University of Michigan, at Ascension Health System, and AmeriPath, a division of Quest Diagnostics. He has more than 30 years experience in medical practice and most recently served as the chief of pathology and laboratory services and director of clinical research for the Comprehensive Urology practice in Royal Oak.
Cradle Genomics: Tristan Orpin, Randy Armant, Richard Shippy, Sascha Drewlo
NIPT startup Cradle Genomics announced its management team this week, which includes Tristan Orpin, Randy Armant, Richard Shippy, and Sascha Drewlo.
Tristan Orpin will serve as San Diego-based Cradle's CEO. He previously served as chief commercial officer and executive VP of clinical genomics at Illumina. Prior to that, Orpin held executive positions at Sequenom and at Bio-Rad Laboratories. Randy Armant is a cofounder and Cradle's VP of research. He is a professor of obstetrics and gynecology at Wayne State University. Richard Shippy is a cofounder and will serve as the company's VP of commercial. He previously served as the senior director of strategic product marketing in reproductive and genetic health at Illumina. Before that, Shippy held management positions in clinical market development at Affymetrix and at GE Healthcare. Sascha Drewlo is a cofounder and will serve as Cradle's VP of development.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.